Home › Type 1 Diabetes › NCT04933851

ACT1VATE: Addressing Emotional Distress to Improve Outcomes Among Diverse Adults With Type 1 Diabetes

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Spanish or English-speaking
* Type 1 diabetes
* Glycosylated Hemoglobin (HbA1c) 7.0% - 12.5% in last 90 days
* Screen positive for diabetes distress

Exclusion Criteria:

* Severe medical or psychological conditions that would interfere with participation based on the opinion of a provider
* Plans to move out of the San Diego area in the next 12 months
* Lack of technology capability required to complete online surveys and telemedicine visit

About the study

This research will compare a psychological intervention ("ACT1VATE") versus diabetes self-management education and support (DSME/S; usual care) in improving clinical, behavioral, psychosocial, process, and cost outcomes among adults with poorly controlled type 1 diabetes (T1D) who are experiencing significant diabetes-related emotional distress and poor glycemic control in a real world, healthcare environment.

What is being tested

• ACT1VATE (behavioral)
• DSME/S (behavioral)

Sponsor: Scripps Whittier Diabetes Institute · Participants: 250 · Started: Oct 25, 2021

Contact the study team

• Haley Sandoval · Phone: 970-497-6701
• Addie Fortmann, PhD · Phone: 858-922-2276

Official record on ClinicalTrials.gov — NCT04933851

Locations in the U.S.

Conditions

• Type 1 Diabetes

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.